AAAAAA
Results:
1-18
|
Results: 18
Authors:
Murer, MG
Yan, Q
Raisman-Vozari, R
Citation: Mg. Murer et al., Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease, PROG NEUROB, 63(1), 2001, pp. 71-124
Authors:
Simon, A
Martin-Martinelli, E
Savy, C
Verney, C
Raisman-Vozari, R
Nguyen-Legros, J
Citation: A. Simon et al., Confirmation of the retinopetal/centrifugal nature of the tyrosine hydroxylase-immunoreactive fibers of the retina and optic nerve in the weaver mouse, DEV BRAIN R, 127(1), 2001, pp. 87-93
Authors:
Douhou, A
Troadec, JD
Ruberg, M
Raisman-Vozari, R
Michel, PP
Citation: A. Douhou et al., Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptors, J NEUROCHEM, 78(1), 2001, pp. 163-174
Authors:
Zarate-Lagunes, M
Gu, WJ
Blanchard, V
Francois, C
Muriel, MP
Mouatt-Prigent, A
Bonici, B
Parent, A
Hartmann, A
Yelnik, J
Boehme, GA
Pradier, L
Moussaoui, S
Faucheux, B
Raisman-Vozari, R
Agid, Y
Brice, A
Hirsch, EC
Citation: M. Zarate-lagunes et al., Parkin immunoreactivity in the brain of human and non-human primates: An immunohistochemical analysis in normal conditions and in Parkinsonian syndromes, J COMP NEUR, 432(2), 2001, pp. 184-196
Authors:
Vila, M
Perier, C
Feger, J
Yelnik, J
Faucheux, B
Ruberg, M
Raisman-Vozari, R
Agid, Y
Hirsch, EC
Citation: M. Vila et al., Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic andelectrophysiological measurements, EUR J NEURO, 12(1), 2000, pp. 337-344
Authors:
Murer, MG
Dziewczapolski, G
Salin, P
Vila, M
Tseng, KY
Ruberg, M
Rubinstein, M
Kelly, MA
Grandy, DK
Low, MJ
Hirsch, E
Raisman-Vozari, R
Gershanik, O
Citation: Mg. Murer et al., The indirect basal ganglia pathway in dopamine D-2 receptor-deficient mice, NEUROSCIENC, 99(4), 2000, pp. 643-650
Authors:
Tseng, KY
Roubert, C
Do, L
Rubinstein, M
Kelly, MA
Grandy, DK
Low, MJ
Gershanik, OS
Murer, MG
Giros, B
Raisman-Vozari, R
Citation: Ky. Tseng et al., Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice, MOL BRAIN R, 80(1), 2000, pp. 1-6
Authors:
Simon, A
Savy, C
Martin-Martinelli, E
Douhou, A
Frederic, F
Verney, C
Nguyen-Legros, J
Raisman-Vozari, R
Citation: A. Simon et al., Paradoxical increase of tyrosine hydroxylase-immunoreactive retinopetal fibers in the weaver mouse, DEV BRAIN R, 121(1), 2000, pp. 113-117
Authors:
Vilpoux, C
Leroux-Nicollet, I
Naudon, L
Raisman-Vozari, R
Costentin, J
Citation: C. Vilpoux et al., Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain, NEUROPHARM, 39(6), 2000, pp. 1075-1082
Authors:
Gu, WJ
Abbas, N
Lagunes, MZ
Parent, A
Pradier, L
Bohme, GA
Agid, Y
Hirsch, EC
Raisman-Vozari, R
Brice, A
Citation: Wj. Gu et al., Cloning of rat parkin cDNA and distribution of parkin in rat brain, J NEUROCHEM, 74(4), 2000, pp. 1773-1776
Authors:
Murer, MG
Ferrario, J
Delfino, M
Dziewczapolski, G
Gershanik, OS
Raisman-Vozari, R
Citation: Mg. Murer et al., Increased [I-125]sulpiride binding in the subthalamic nucleus of rats withnigrostriatal lesions, NEUROREPORT, 10(7), 1999, pp. 1501-1505
Authors:
Murer, MG
Raisman-Vozari, R
Yan, Q
Ruberg, M
Agid, Y
Michel, PP
Citation: Mg. Murer et al., Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons, NEUROREPORT, 10(4), 1999, pp. 801-805
Authors:
Parain, K
Murer, MG
Yan, Q
Faucheux, B
Agid, Y
Hirsch, E
Raisman-Vozari, R
Citation: K. Parain et al., Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra, NEUROREPORT, 10(3), 1999, pp. 557-561
Authors:
Agid, Y
Ahlskog, E
Albanese, A
Calne, D
Chase, T
De Yebenes, J
Factor, S
Fahn, S
Gershanik, O
Goetz, C
Koller, W
Kurth, M
Lang, A
Lees, A
Lewitt, P
Marsden, D
Melamed, E
Michel, PP
Mizuno, Y
Obeso, J
Oertel, W
Olanow, W
Poewe, W
Pollak, P
Przedzorski, S
Quinn, N
Raisman-Vozari, R
Rajput, A
Stocchi, F
Tolosa, E
Citation: Y. Agid et al., Levodopa in the treatment of Parkinson's disease: A consensus meeting, MOVEMENT D, 14(6), 1999, pp. 911-913
Authors:
Murer, MG
Boissiere, F
Yan, Q
Hunot, S
Villares, J
Faucheux, B
Agid, Y
Hirsch, E
Raisman-Vozari, R
Citation: Mg. Murer et al., An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease, NEUROSCIENC, 88(4), 1999, pp. 1015-1032
Authors:
Murer, MG
Raisman-Vozari, R
Gershanik, O
Citation: Mg. Murer et al., Levodopa in Parkinson's disease - Neurotoxicity issue laid to rest?, DRUG SAFETY, 21(5), 1999, pp. 339-352
Authors:
Vila, M
Marin, C
Ruberg, M
Jimenez, A
Raisman-Vozari, R
Agid, Y
Tolosa, E
Hirsch, EC
Citation: M. Vila et al., Systemic administration of NMDA and AMPA receptor antagonists reverses theneurochemical changes induced by nigrostriatal denervation in basal ganglia, J NEUROCHEM, 73(1), 1999, pp. 344-352
Authors:
Savy, C
Martin-Martinelli, E
Simon, A
Duyckaerts, C
Verney, C
Adelbrecht, C
Raisman-Vozari, R
Nguyen-Legros, J
Citation: C. Savy et al., Altered development of dopaminergic cells in the retina of Weaver mice, J COMP NEUR, 412(4), 1999, pp. 656-668
Risultati:
1-18
|